{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:44:01Z","timestamp":1785825841071,"version":"3.56.0"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T00:00:00Z","timestamp":1483920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"United States Agency for International Development and the President\u2019s Emergency Plan for AIDS Relief","award":["674-A-00-08-00005-00"],"award-info":[{"award-number":["674-A-00-08-00005-00"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0168659","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T23:23:53Z","timestamp":1484004233000},"page":"e0168659","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation"],"prefix":"10.1371","volume":"12","author":[{"given":"Judith","family":"Mwansa-Kambafwile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boitumelo","family":"Maitshotlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,1,9]]},"reference":[{"key":"ref1","unstructured":"Organization WH. Global TB Report. 2015."},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5588\/ijtld.14.0653","article-title":"The impact of Xpert\u00ae MTB\/RIF in sparsely populated rural settings","volume":"19","author":"T Van Den Handel","year":"2015","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"e1001760","DOI":"10.1371\/journal.pmed.1001760","article-title":"Impact of Xpert MTB\/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial","volume":"11","author":"HS Cox","year":"2014","journal-title":"PLoS medicine"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"e1001766","DOI":"10.1371\/journal.pmed.1001766","article-title":"Impact of replacing smear microscopy with Xpert MTB\/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial","volume":"11","author":"B Durovni","year":"2014","journal-title":"PLoS medicine"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/S2214-109X(15)00100-X","article-title":"Xpert MTB\/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB\/RIF","volume":"3","author":"GJ Churchyard","year":"2015","journal-title":"The Lancet Global health"},{"issue":"6","key":"ref6","doi-asserted-by":"crossref","first-page":"e65421","DOI":"10.1371\/journal.pone.0065421","article-title":"Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB\/RIF at a primary care clinic in Johannesburg, South Africa","volume":"8","author":"CF Hanrahan","year":"2013","journal-title":"PloS one"},{"issue":"9915","key":"ref7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0140-6736(13)62073-5","article-title":"Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB\/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial","volume":"383","author":"G Theron","year":"2014","journal-title":"Lancet"},{"key":"ref8","unstructured":"NDOH. National Tuberculosis Management Guidelines. In: Health NDo, editor. Pretoria: Fishwicks PTA; 2014."},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2471\/BLT.13.124800","article-title":"Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis","volume":"92","author":"P MacPherson","year":"2014","journal-title":"Bulletin of the World Health Organization"},{"issue":"2","key":"ref10","first-page":"157","article-title":"How long are TB patients infectious?","volume":"163","author":"K Schwartzman","year":"2000","journal-title":"CMAJ: Canadian Medical Association Journal"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/502145","article-title":"Relative Versus Absolute Noncontagiousness of Respiratory Tuberculosis on Treatment","volume":"24","author":"R Long","year":"2003","journal-title":"Infection Control and Hospital Epidemiology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2334-14-19","article-title":"Time to first consultation, diagnosis and treatment of TB among patients attending a referral hospital in Northwest, Ethiopia","volume":"14","author":"SA Yimer","year":"2014","journal-title":"BMC infectious diseases"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"e1001067","DOI":"10.1371\/journal.pmed.1001067","article-title":"Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB\/RIF Assay: A Prospective Study","volume":"8","author":"SD Lawn","year":"2011","journal-title":"PLoS medicine"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.5588\/ijtld.15.0013","article-title":"The patient impact of point-of-care vs. laboratory placement of Xpert((R)) MTB\/RIF","volume":"19","author":"CF Hanrahan","year":"2015","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"603","DOI":"10.5588\/ijtld.12.0505","article-title":"Tuberculosis patients in primary care do not start treatment. What role do health system delays play?","volume":"17","author":"MM Claassens","year":"2013","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.5588\/ijtld.12.0131","article-title":"Location of Xpert(R) MTB\/RIF in centralised laboratories in South Africa undermines potential impact","volume":"16","author":"SD Lawn","year":"2012","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.trstmh.2008.04.027","article-title":"Dose\u2013response relationship between treatment delay of smear-positive tuberculosis patients and intra-household transmission: a cross-sectional study","volume":"102","author":"X Lin","year":"2008","journal-title":"Transactions of The Royal Society of Tropical Medicine and Hygiene"},{"issue":"1","key":"ref18","first-page":"25","article-title":"'Lost' smear-positive pulmonary tuberculosis cases: where are they and why did we lose them?","volume":"9","author":"SB Squire","year":"2005","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"7","key":"ref19","first-page":"820","article-title":"Initial default from tuberculosis treatment: how often does it happen and what are the reasons?","volume":"12","author":"E Botha","year":"2008","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/CMR.00042-10","article-title":"HIV and Tuberculosis: a Deadly Human Syndemic","volume":"24","author":"CK Kwan","year":"2011","journal-title":"Clinical Microbiology Reviews"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0168659","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:41:43Z","timestamp":1589020903000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0168659"}},"subtitle":[],"editor":[{"given":"Pere-Joan","family":"Cardona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,9]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0168659","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,9]]}}}